Behandling med acetylsalicylsyre kan forebygge præeklampsi hos gravide kvinder i højrisiko

TY - JOUR

T1 - Behandling med acetylsalicylsyre kan forebygge præeklampsi hos gravide kvinder i højrisiko

AU - Käehne, Line Vedel

AU - Lundin, Ingeborg Christina Rørbye

PY - 2017

Y1 - 2017

N2 - Pre-eclampsia is a major contributor to perinatal morbidity and mortality. Large studies of high-risk pregnant women have shown reduced risk of developing pre-eclampsia when they are treated with low-dose acetylsalicylic acid in early pregnancy. Treatment is also effective in preventing intrauterine growth restriction, preterm birth and perinatal death. No major side effects, including risk of malformations or miscarriage, are reported. It is important that general practitioners are aware of women who have an increased risk of developing pre-eclampsia, so that treatment with 100 mg of acetylsalicylic acid can be started early in pregnancy.

AB - Pre-eclampsia is a major contributor to perinatal morbidity and mortality. Large studies of high-risk pregnant women have shown reduced risk of developing pre-eclampsia when they are treated with low-dose acetylsalicylic acid in early pregnancy. Treatment is also effective in preventing intrauterine growth restriction, preterm birth and perinatal death. No major side effects, including risk of malformations or miscarriage, are reported. It is important that general practitioners are aware of women who have an increased risk of developing pre-eclampsia, so that treatment with 100 mg of acetylsalicylic acid can be started early in pregnancy.

M3 - Tidsskriftartikel

C2 - 28416068

SN - 0041-5782

VL - 179

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 14

M1 - V07160511

ER -